Journal List > J Korean Ophthalmol Soc > v.56(9) > 1010087

Noh and Kim: Comparison of Clinical Features in Hypermetropic Children According to Refractive Error

Abstract

Purpose

To investigate risk factors of esotropia, anisometropia and amblyopia and compare the clinical features in hyper-metropic children according to the amount of hyperopia.

Methods

This study included 377 patients with cycloplegic refractive error of +1 D or greater at first visit. Patients were divided into 3 groups according to the refractive error. Odds ratios were calculated to evaluate the association of clinical risk factors with esotropia, anisometropi and amblyopia. Clinical features were compared between surgical and non-surgical groups.

Results

Hyperopia <+6 D showed greater odds of anisometropia. Hyperopia of ≥+6 D showed greater odds of bilateral am-blyopia to 14.796 and hyperopia of <+6 D increased odds of unilateral amblyopia. Moderate hyperopia (≥3 D to <6 D) increased the odds ratio for development of esotropia to 1.862. Patients with anisometropia ≥2 D had a 5.386 times increased odds of eso-tropia and those younger than 2 years had a 5.578 times increased odds of esotropia. Surgical groups showed lower amount of hyperopia than non-surgical groups. Hyperopia <+3 D had higher prevalence of esotropic surgery (50.72%).

Conclusions

Moderate hyperopia and anisometroia ≥2 D increased the risk for development of esotropia. Greater prevalence of bilateral amblyopia and lower prevalence of esotrpia was found predominantly in groups with higher amount of hyperopia. We recommend optical correction at an early age with higher hyperopia and surgical treatment should be considered for esotropic children with lower hyperopia.

References

1. Mutti DO, Mitchell GL, Jones LA. . Axial growth and changes in lenticular and corneal power during emmetropization in infants. Invest Ophthalmol Vis Sci. 2005; 46:3074–80.
crossref
2. Ingram RM, Arnold PE, Dally S, Lucas J. Results of a randomised trial of treating abnormal hypermetropia from the age of 6 months. Br J Ophthalmol. 1990; 74:158–9.
crossref
3. Giordano L, Friedman DS, Repka MX. . Prevalence of re-fractive error among preschool children in an urban population: the Baltimore Pediatric Eye Disease Study. Ophthalmology. 2009; 116:739–46.
crossref
4. Atkinson J, Braddick O, Robier B. . Two infant vision screen-ing programmes: prediction and prevention of strabismus and am-blyopia from photo- and videorefractive screening. Eye (Lond). 1996; 10:189–98.
crossref
5. Greenberg AE, Mohney BG, Diehl NN, Burke JP. Incidence and types of childhood esotropia: a population-based study. Ophthalmology. 2007; 114:170–4.
6. Birch EE, Fawcett SL, Morale SE. . Risk factors for accom-modative esotropia among hypermetropic children. Invest Ophthalmol Vis Sci. 2005; 46:526–9.
crossref
7. Cotter SA, Varma R, Tarczy-Hornoch K. . Risk factors asso-ciated with childhood strabismus: the multi-ethnic pediatric eye disease and Baltimore pediatric eye disease studies. Ophthalmology. 2011; 118:2251–61.
8. Choi DK, Choi MY. Clinical manifestation of patients with accom-modative esotropia for 10 years. J Korean Ophthalmol Soc. 2011; 52:1331–6.
crossref
9. Jun JH, Lee YC, Lee SY. Clinical features of refractive accom-modative esotropia according to degree of hypermetropia. J Korean Ophthalmol Soc. 2008; 49:617–22.
crossref
10. Kang IS, Park SW, Park YG. Clinical features of refractive accom-modative esotropia: long-term study. J Korean Ophthalmol Soc. 2008; 49:487–92.
crossref
11. Lim SJ, Cho YA. Bilateral hypermetropic amblyopia-in children with hyperopia of +6 diopters or more-. J Korean Ophthalmol Soc. 1994; 35:715–20.
12. Huynh SC, Wang XY, Ip J. . Prevalence and associations of anisometropia and aniso-astigmatism in a population based sample of 6 year old children. Br J Ophthalmol. 2006; 90:597–601.
crossref
13. Tarczy-Hornoch K. The epidemiology of early childhood hyperopia. Optom Vis Sci. 2007; 84:115–23.
crossref
14. Schoenleber DB, Crouch ER Jr. Bilateral hypermetropic amblyopia. J Pediatr Ophthalmol Strabismus. 1987; 24:75–7.
crossref
15. Friedman Z, Neumann E, Abel-Peleg B. Outcome of treatment of marked ametropia without strabismus following screening and di-agnosis before the age of three. J Pediatr Ophthalmol Strabismus. 1985; 22:54–7.
crossref
16. Friedman Z, Neumann E, Hyams SW, Peleg B. Ophthalmic screen-ing of 38,000 children, age 1 to 2 1/2 years, in child welfare clinics. J Pediatr Ophthalmol Strabismus. 1980; 17:261–7.
crossref
17. Tarczy-Hornoch K, Varma R, Cotter SA. . Risk factors for de-creased visual acuity in preschool children: the multi-ethnic pedia-tric eye disease and Baltimore pediatric eye disease studies. Ophthalmology. 2011; 118:2262–73.
18. Klimek DL, Cruz OA, Scott WE, Davitt BV. Isoametropic am-blyopia due to high hyperopia in children. J AAPOS. 2004; 8:310–3.
crossref
19. Chen W, Chen J, Zhang F. . Visual outcome in isoametropic amblyopic children with high hyperopia and the effect of therapy on retinal thickness. Am J Ophthalmol. 2013; 155:536–43.e1.
crossref
20. Weakley DR Jr, Birch E. The role of anisometropia in the develop-ment of accommodative esotropia. Trans Am Ophthalmol Soc. 2000; 98:71–6. discussion 76-9.
crossref
21. Coats DK, Avilla CW, Paysse EA. . Early-onset refractive ac-commodative esotropia. J AAPOS. 1998; 2:275–8.
crossref
22. Berk AT, Koçak N, Ellidokuz H. Treatment outcomes in refractive accommodative esotropia. J AAPOS. 2004; 8:384–8.
crossref
23. Birch EE. Marshall Parks lecture. Binocular sensory outcomes in accommodative ET. J AAPOS. 2003; 7:369–73.

Table 1.
Clinical characteristics of the subjects according to the amount of hyperopia
Hyperopia p-value
≥1 D to <3 D (n = 156) ≥3 D to <6 D (n = 169) ≥6 D (n = 52)
Age at first visit (years) 3.96 ± 2.15 4.03 ± 2.17 3.73 ± 2.21 0.866
Final BCVA 0.87 ± 0.16 0.83 ± 0.20 0.84 ± 0.20 0.294
Initial SE (D) 1.95 ± 0.50 4.16 ± 0.78 7.30 ± 0.99 <0.001
Final SE (D) 0.84 ± 1.14 2.82 ± 1.48 5.45 ± 1.97 <0.001
Anisometropia > 1 D (n, %) 39/156 (25.0) 45/169 (26.63) 6/52 (11.54) 0.069
Anisometropia > 2 D (n, %) 25/156 (16.03) 25/169 (14.79) 1/52 (1.92) 0.001
Unilateral amblyopia (n, %) 45/156 (28.85) 47/169 (27.81) 6/52 (11.54) 0.019
Bilateral ambylopia (n, %) 8/156 (5.13) 14/169 (8.28) 20/52 (38.46) <0.001
Acc esotropia (n, %) 33/156 (21.15) 78/169 (46.15) 9/52 (17.31) 0.015
Surgery of ET (n, %) 35/69 (50.72) 20/89 (22.47) 2/21 (9.52) 0.001

Values are presented as mean ± SD unless otherwise indicated. D = diopter; BCVA = best-corrected visual acuity; SE = spherical equivalent; Acc = accommodative; ET = esotropia.

One way analysis of variance (ANOVA).

Table 2.
Clinical characteristics in children of the same age according to the amount of hyperopia
Hyperopia
≥1 D to <3 D (n = 14) ≥3 D to <6 D (n = 13) ≥6 D (n = 8) p-value
Spherical equivalent (D)
Initial 2.28 ± 0.39 4.00 ± 0.72 6.56 ± 1.12 <0.001
Final 1.24 ± 0.91 2.42 ± 1.07 4.63 ± 1.71 <0.001
Anisometropia (D)
Initial 0.43 ± 0.65 0.50 ± 0.76 0.15 ± 0.38 0.145
Final 0.73 ± 0.79 0.75 ± 0.89 0.58 ± 0.52 0.546
Unilateral amblyopia (n, %)
Initial 1/14 (7.14) 1/13 (7.69) 0/8 (0.0) 0.533
Final 2/14 (14.29) 2/13 (15.38) 2/8 (25.0) 0.502
Bilateral amblyopia (n, %)
Initial 1/14 (7.14) 1/13 (7.69) 3/8 (37.5) 0.387
Final 0/14 (0.0) 0/13 (0.0) 2/8 (25.0) 0.144
Accommodative ET (n, %)
Initial 3/14 (21.43) 8/13 (61.54) 4/8 (50.0) 0.212
Final 2/14 (14.29) 8/13 (61.54) 4/8 (50.0) 0.065
Hyperopic reduction rate (D/year) 0.25 ± 0.19 0.30 ± 0.18 0.39 ± 0.36 0.435

Values are presented as mean ± SD unless otherwise indicated. D = diopter; ET = esotropia.

3 years old;

Kruskal-Wallis test;

5 years follow-up.

Table 3.
Hyperopia and risk of anisometropia
Risk of anisometropia (≥1 D) Risk of anisometropia (≥2 D)
OR 95% CI p-value OR 95% CI p-value
Hyperopia
≥1 D to <3 D 1.769 0.785-3.987 0.114 1.232 1.137-1.335 <0.001
≥3 D to <6 D 1.855 0.829-4.154 0.089 1.217 1.128-1.312 <0.001
≥6 D 0.741 0.240-2.286 0.407 1.024 0.978-1.072 0.467

D = diopter; OR = odds ratio; CI = confidential interval.

Chi-square test.

Table 4.
Hyperopia and risk of amblyopia
Risk of unilateral amblyopia Risk of bilateral amblyopia
OR 95% CI p-value OR 95% CI p-value
Hyperopia
≥1 D to <3 D 2.854 1.239-6.572 0.008 1.480 0.303-7.224 0.474
≥3 D to <6 D 2.992 1.186-7.548 0.011 2.511 0.550-11.467 0.179
≥6 D 1.356 0.418-4.393 0.416 14.796 3.173-68.999 <0.001

D = diopter; OR = odds ratio; CI = confidential interval.

Chi-square test.

Table 5.
Risk factors for childhood esotropia
Risk factors Risk of esotropia
OR 95% CI p-value
Hyperopia
≥1 D to <3 D 1.263 0.657-2.431 0.483
≥3 D to <6 D 1.862 1.169-3.579 0.044
≥6 D 1.067 0.469-2.428 0.877
Anisometropia
≥1 D 1.090 0.609-1.964 0.699
≥2 D 5.386 2.046-14.179 0.001
≥2 D with hyperopia (<3 D) 8.039 2.637-24.508 <0.001
≥2 D with hyperopia (≥3 D) 3.231 1.276-8.182 0.009
Age at initial visit
<2 years 5.578 3.208-9.669 <0.001

D = diopter; OR = odds ratio; CI = confidential interval.

Chi-square test;

Logistic regression analysis.

Table 6.
Comparison between surgery and non-surgery groups
Non-surgery group (n = 132) Surgery group (n = 69) p-value
Age at first visit (years) 3.49 ± 2.01 3.04 ± 2.69 0.191
Spherical equivalent (D) 3.75 ± 1.87 2.39 ± 1.63 <0.001
Anisometropia (D) 0.58 ± 0.66 0.59 ± 0.87 0.912
Anisometropia >1 D (n, %) 26/129 (20.16) 13/69 (18.84) 0.997
Unilateral amblyopia (n, %) 35/132 (26.52) 17/69 (24.64) 0.473
Bilateral ambylopia (n, %) 3/132 (2.27) 0/69 (0.0) 0.083
Glasses wearing (n, %) 114/129 (88.37) 50/69 (72.46) 0.014
Angle of deviation (PD)
Without correction 22.00 ± 12.44 31.15 ± 14.04 0.001
With correction 2.98 ± 5.10 24.77 ± 14.70 <0.001

Values are presented as mean ± SD unless otherwise indicated. D = diopter; PD = prism diopter.

Independent t-test.

Table 7.
Comparison of clinical characteristics in esotropic groups
Acc (n = 102) Partial Acc (n = 18) Non-Acc (n = 48) Infantile (n = 31) p-value
Age at first visit (years) 3.81 ± 2.29 3.78 ± 1.87 3.44 ± 2.24 1.32 ± 1.17 <0.001
Final BCVA 0.84 ± 0.19 0.88 ± 0.17 0.83 ± 0.20 0.83 ± 0.13 0.833
Initial SE (D) 4.09 ± 1.79 3.19 ± 1.57 2.26 ± 1.66 2.27 ± 1.54 <0.001
Final SE (D) 3.09 ± 1.90 2.04 ± 1.71 0.64 ± 1.31 1.27 ± 1.55 <0.001
Anisometropia (D) 0.59 ± 0.69 0.51 ± 0.66 0.72 ± 0.97 0.41 ± 0.41 0.321
Unilateral amblyopia (n, %) 36/102 (35.29) 8/18 (44.44) 5/48 (10.42) 6/31 (19.35) 0.003
Bilateral ambylopia (n, %) 3/102 (2.94) 0/18 0/48 0/31 0.413
Associated strabismus (n, %) 10/102 (9.80) 3/18 (16.67) 13/48 (27.08) 7/31 (22.58) 0.036
Angle of deviation
Without correction 21.70 ± 8.90 34.50 ± 13.03 26.80 ± 18.63 31.36 ± 9.24 0.013
With correction 1.63 ± 3.19 19.50 ± 9.97 24.00 ± 17.22 25.00 ± 0.00 <0.001
Surgery of ET (n, %) 10/102 (9.80) 11/18 (61.11) 23/48 (47.92) 25/31 (80.65) <0.001
Success rate of surgery (n, %) 10/10 (100) 8/11 (72.73) 16/23 (69.57) 12/25 (48.0) 0.015

Values are presented as mean ± SD unless otherwise indicated. Acc = accommodative esotropia; BCVA = best-corrected visual acuity; SE = spherical equivalent; D = diopter; ET = esotropia.

One way analysis of variance (ANOVA);

Non-refractive accommodative esotropia.

TOOLS
Similar articles